A DOUBLE-BLIND COMPARISON OF A NOVEL INDANONE DIURETIC (MK-196) WITH HYDROCHLOROTHIAZIDE IN THE TREATMENT OF ESSENTIAL HYPERTENSIONWILHELMSSON CE; VEDIN JA; MOERLIN C et al.1979; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1979; VOL. 8; NO 3; PP. 261-266; BIBL. 14 REF.Article

The statistical evaluation of a three-period two-treatment crossover pharmacokinetic drug interaction studyCIMINERA, J. L; BOLOGNESE, J. A; GREGG, M. H et al.Biometrics. 1987, Vol 43, Num 3, pp 713-718, issn 0006-341XArticle

COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects : a double blind crossover study comparing rofecoxib with placebo and indomethacinSIGTHORSSON, G; CRANE, R; SIMON, T et al.Gut. 2000, Vol 47, Num 4, pp 527-532, issn 0017-5749Article

Two new criteria for choosing sample size in combinatorial chemistryPENG-LIANG ZHAO; NACHBAR, R. B; BOLOGNESE, J. A et al.Journal of medicinal chemistry (Print). 1996, Vol 39, Num 2, pp 350-352, issn 0022-2623Article

Toxicity of avermectins to diamondback moth (Lepidoptera: Plutellidae) populations : Implications for susceptibility monitoringLASOTA, J. A; SHELTON, A. M; BOLOGNESE, J. A et al.Journal of economic entomology. 1996, Vol 89, Num 1, pp 33-38, issn 0022-0493Article

Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E₂ in healthy volunteers: a double blind investigationSCIBERRAS, D. G; GOLDENBERG, M. M; BOLOGNESE, J. A et al.British journal of clinical pharmacology. 1987, Vol 24, Num 6, pp 753-761, issn 0306-5251Article

Enalapril in congestive heart failure: acute and chronic invasive hemodynamic evaluationGOMEZ, H. J; CIRILLO, V. J; DAVIES, R. O et al.International journal of cardiology. 1986, Vol 11, Num 1, pp 37-48, issn 0167-5273Article

Validation of a symptoms questionnaire for benign prostatic hyperplasiaBOLOGNESE, J. A; KOZLOFF, R. C; KUNITZ, S. C et al.The Prostate. 1992, Vol 21, Num 3, pp 247-254, issn 0270-4137Article

Pharmacokinetics of lisinopril (IV/PO) in healthy volunteersBEERMANN, B; TILL, A. E; GOMEZ, H. J et al.Biopharmaceutics & drug disposition. 1989, Vol 10, Num 4, pp 397-409, issn 0142-2782Article

Lisinopril: dose-peak effect relationship in essential hypertensionCIRILLO, V. J; GOMEZ, H. J; SALONEN, J et al.British journal of clinical pharmacology. 1988, Vol 25, Num 5, pp 533-538, issn 0306-5251Article

Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trialsHAWKEY, C. J; LAINE, L; HARPER, S. E et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 10, pp 1593-1601, issn 0269-2813Article

Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasiaGIRMAN, C. J; KOLMAN, C; LISS, C. L et al.The Prostate. 1996, Vol 29, Num 2, pp 83-90, issn 0270-4137Article

A randomized trial of the efficacy and tolerability of the COX-2 inhibitor Rofecoxib vs ibuprofen in patients with osteoarthritisDAY, R; MORRISON, B; KRUPA, D et al.Archives of internal medicine (1960). 2000, Vol 160, Num 12, pp 1781-1787, issn 0003-9926Article

A randomized trial comparing the effect of Rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritisLAINE, L; HARPER, S; SIMON, T et al.Gastroenterology (New York, NY. 1943). 1999, Vol 117, Num 4, pp 776-783, issn 0016-5085Article

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritisSCHNITZER, T. J; TRUITT, K; FLEISCHMANN, R et al.Clinical therapeutics. 1999, Vol 21, Num 10, pp 1688-1702, issn 0149-2918Article

Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adultsMURPHY, M. G; BACH, M. A; PLOTKIN, D et al.Journal of bone and mineral research (Print). 1999, Vol 14, Num 7, pp 1182-1188, issn 0884-0431Article

Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofenLANZA, F. L; RACK, M. F; SIMON, T. J et al.Alimentary pharmacology & therapeutics. 1999, Vol 13, Num 6, pp 761-767, issn 0269-2813Article

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDsLANGMAN, M. J; JENSEN, D. M; WATSON, D. J et al.JAMA, the journal of the American Medical Association. 1999, Vol 282, Num 20, pp 1929-1933, issn 0098-7484Article

Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) segretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young menCOPINSCHI, G; VAN ONDERBERGEN, A; L'HERMITE-BALERIAUX, M et al.The Journal of clinical endocrinology and metabolism. 1996, Vol 81, Num 8, pp 2776-2782, issn 0021-972XArticle

Pharmacokinetics of repeted single oral doses of enalapril maleate (MK-421) in normal volunteersTILL, A. E; GOMEZ, H. J; HICHENS, M et al.Biopharmaceutics & drug disposition. 1984, Vol 5, Num 3, pp 273-280, issn 0142-2782Article

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis a randomized, double-blind, placebo-controlled trialHAWKEY, C; LAINE, L; SIMON, T et al.Arthritis and rheumatism. 2000, Vol 43, Num 2, pp 370-377, issn 0004-3591Article

Effective dose range of enalapril in mild to moderate essential hypertensionBERGSTRAND, R; HERLITZ, H; JOHANSSON, S et al.British journal of clinical pharmacology. 1985, Vol 19, Num 5, pp 605-611, issn 0306-5251Article

Effect of specific COX-2 inhibition in osteoarthritis of the knee : A 6 week double blind, placebo controlled pilot study of rofecoxibEHRICH, E. W; SCHNITZER, T. J; GERTZ, B. J et al.Journal of rheumatology. 1999, Vol 26, Num 11, pp 2438-2447, issn 0315-162XArticle

The effect of enalapril on serum prolactinMCNABB, W. R; BROOKS, B. A; NOORMOHAMED, F et al.British journal of clinical pharmacology. 1983, Vol 15, Num 6, pp 752-754, issn 0306-5251Article

Lovastatin (Mevinolin) in the treatment of heterozygous familial hypercholesterolemia: a multicenter studyHAVEL, R. J; HUNNINGHAKE, D. B; LEES, A. M et al.Annals of internal medicine. 1987, Vol 107, Num 5, pp 609-615, issn 0003-4819Article